Artificial intelligence detects new type of prostate cancer

Prostate cancer research using artificial intelligence has identified two subtypes of cells - Photo: Getty

Research on prostate cancer using artificial intelligence has collected data from DNA and identified two types of extracellular matrix, known as evotypes, that influence the development of the disease.

There are two types of prostate cancer.

"This research is really important because until now we thought prostate cancer was just one type of disease. But now, with advances in artificial intelligence, we can show that there are two different types at play," said Professor Colin Cooper, from UEA's Norwich Medical School. According to Cancer Research UK's senior scientific director, Rupal Mistry, prostate cancer is the most common cancer affecting men in the UK, with around 52,000 cases a year, or 1 in 8 men. The research demonstrates how prostate cancer can affect physical, emotional and mental health. In the paper, the scientists hope the findings will help save thousands of lives in the future and revolutionise the diagnosis and treatment of prostate cancer.

Tailored treatment

The findings could lead to tailored treatments for individual patients based on genetic testing, which will also be carried out using AI. "The study demonstrates that prostate tumours evolve along multiple pathways, leading to two distinct disease types," said Dan Woodcock, a researcher at the University of Oxford. "This understanding is important because it allows tumours to be classified based on how the cancer develops, rather than just on individual gene mutations or expression patterns." Meanwhile, Naomi Elster, director of research at the Prostate Cancer Research Centre, stressed the need for further understanding of what it really means to diagnose prostate cancer. "We don't know enough about what it means to diagnose prostate cancer," says Elster. "There are a lot of men who have a disease that is or could become aggressive, and being able to treat these diseases more effectively is very important. But the other side of the problem is that too many men are living with side effects from cancer treatments they may never need."

New therapy helps treat prostate cancer early

TTO - Scientists at the Institute for Biomedical Research - University College London (UK) have announced the successful testing of a method using light energy to treat early-stage prostate cancer.

Tuoitre.vn Source